Suppression by Chai-hu-gui-zhi-tang of the development of liver lesions induced by N-nitrosomorpholine in Sprague-Dawley rats

Cancer Letters

Volumn 152, Issue 1, 2000, Pages 31-36

  Tatsuta, Masaharu ^a   Iishi, Hiroyasu ^a   Baba, Miyako ^a   Narahara, Hiroyuki ^a   Yano, Hiroyuki ^a   Sakai, Noriko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Liver lesions; N Nitrosmorpholine; TJ 10

Indexed keywords

GLUTATHIONE TRANSFERASE; NITROSOMORPHOLINE; SHOSAIKOTO GO KEISHIKASHAKUYAKUTO;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HISTOCHEMISTRY; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL DIVISION; DRUGS, CHINESE HERBAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NITROSAMINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034724956     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00429-2     Document Type: Article

References (16)

1. Tatsuta M., lishi H., Baba M., Nakaizumi A., Uehara H. Inhibition by Xiao-chai-hu-tang (TJ9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats. Jpn. J. Cancer Res. 82:1991;987-992.
2. Yamamoto M., Kumagai A. Bupleuri Radix and chronic hepatitis: experimental and clinical studies. In: Proc. Symposium 9 and Satellite Symposium 8 of the 17th International Congress of Internal Medicine. Excerpta Med. Tokyo. 1984;238-247.
3. Itoh T., Shibahara N., Mantani N., Tahara E., Shimada Y., Terasawa K. Effect of Kampo treatment on chronic viral hepatitis on the basis of traditional diagnosis. J. Trad. Med. 14:1997;204-210.
4. Stemberger L.A., Hardy P.H. Jr., Cuculis J.J., Meyer H.G. The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J. Histochem. Cytochem. 18:1970;315-333.
5. Institute of Laboratory Animal Resources. Histologic typing of liver tumors of the rat. J. Natl. Cancer Inst. 64 (1980) 177-206.
6. Gratzner H.G. Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science. 218:1982;474-475.
7. Morstyn G., Hsu S.M., Kinsella T., Gratzner H., Russo A., Mitchell J.B. Bromodeoxyuridine in tumors and chromosomes detected with monoclonal antibody. J. Clin. Invest. 72:1983;1844-1850.
8. Törmänen U., Eerola A.-K., Painio P., Vähäkangas K., Sonini Y., Sormonen R., Bloigu R., Lehto V.-P., Pääkko P. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res. 55:1995;5595-5602.
9. Miller R.G. Jr. Simultaneous Statistical Inference. 1966;McGraw-Hill, New York.
10. Gion T., Takenaka K., Nishizaki T., Shirabe H., Shimada M., Fujisawa T., Sugimachi K. Inhibition by TJ-9 and TJ-10 of the growth of a hepatocellular cell line. J. Jpn. Soc. Cancer Ther. 31:1996;717.
11. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
12. Williams G.T. Programmed cell death: apoptosis and oncogenesis. Cell. 65:1991;1097-1098.
13. Tsujitani S., Shirai H., Tatebe S., Sugamura K., Ohfuji S., Gomyo Y., Itoh H., Kaibara N. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer. 77:1996;1711-1716.
14. Tatsuta M., lishi H., Baba M., Hirasawa R., Yano H., Sakai N., Nakaizumi A. Attenuation by all-trans-retinoic acid of sodium chloride-enhanced gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitroso-guanidine in Wistar rats. Br. J. Cancer. 79:1999;732-736.
15. Tsuda H., Ozaki K., Uwagawa S., Yamaguchi S., Hakoi K., Aoki T., Kato K., Sato K., Ito N. Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats. Jpn. J. Cancer Res. 83:1992;1154-1165.
16. Williams G.M. Interventive prophylaxis of liver cancer. Eur. J. Cancer Prev. 3:1994;89-99.